March 10, 2025 · Form 4 insider transaction
Tatsis Ourania sold 3,242 shares of Vertex Pharmaceuticals Incorporated at $499.99 per share, a transaction worth $1.62M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.